Varaico: Literature-Extracted Genetic Variants

Gene:GLA
Variant:p.E66K
Back to variants list

GLA

NM_000169.3:p.E66K

Associated Papers

Identification and functional characterization of the first deep intronic GLA mutation (IVS4+1326C>T) causing renal variant of Fabry disease.

Dai X et al.

Orphanet Journal of Rare Diseases, 2022

Fabry disease and kidney involvement: starting from childhood to understand the future.

Chimenz R et al.

Pediatric Nephrology (berlin, Germany), 2022

Assessment of Gene Variant Amenability for Pharmacological Chaperone Therapy with 1-Deoxygalactonojirimycin in Fabry Disease.

Lukas J et al.

International Journal of Molecular Sciences, 2020

Challenging popular tools for the annotation of genetic variations with a real case, pathogenic mutations of lysosomal alpha-galactosidase.

Cimmaruta C et al.

Bmc Bioinformatics, 2018

30497360 (PubMed )
Supplement: 12859_2018_2416_MOESM2_ESM.xlsx › ST2

Fabry Nephropathy: An Evidence-Based Narrative Review.

Del Pino M et al.

Kidney & Blood Pressure Research, 2018

Impact of immunosuppressive therapy on therapy-neutralizing antibodies in transplanted patients with Fabry disease.

Lenders M et al.

Journal of Internal Medicine, 2017

The validation of pharmacogenetics for the identification of Fabry patients to be treated with migalastat.

Benjamin ER et al.

Genetics in Medicine : Official Journal of the American College of Medical Genetics, 2017

27657681 (PubMed )
Supplement: gim2016122x1.zip › Supplemental_Appendix_2_12152015.xlsx › Unknown

The Large Phenotypic Spectrum of Fabry Disease Requires Graduated Diagnosis and Personalized Therapy: A Meta-Analysis Can Help to Differentiate Missense Mutations.

Citro V et al.

International Journal of Molecular Sciences, 2016

27916943 (PubMed )
Supplement: ijms-17-02010-s001.zip › ijms-157565-supplementary_file_1_done.xlsx › Tabella_aggiornamento

The CDC Hemophilia B mutation project mutation list: a new online resource.

Li T et al.

Molecular Genetics & Genomic Medicine, 2013

24498619 (PubMed )
Supplement: mgg30001-0238-SD1.xlsx › CHBMP_Mutation_List

Comparative study of structural changes caused by different substitutions at the same residue on α-galactosidase A.

Saito S et al.

Plos One, 2013

Safety of agalsidase alfa in patients with Fabry disease under 7 years.

Ramaswami U et al.

Acta Paediatrica (oslo, Norway : 1992), 2011

Enzyme replacement therapy with agalsidase alfa in children with Fabry disease.

Ramaswami U et al.

Acta Paediatrica (oslo, Norway : 1992), 2007

Chronic renal failure and proteinuria in adulthood: Fabry disease predominantly affecting the kidneys.

Cybulla M et al.

American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation, 2005

Thirty-four novel mutations of the GLA gene in 121 patients with Fabry disease.

Schäfer E et al.

Human Mutation, 2005

Select a paper to view details
UCSC Genome Browser·Imprint·Privacy·Terms·Feedback·Email Updates·

Regarding the variants extracted from papers and shown text snippets from research papers, the following holds: "Some rights reserved. This work permits non-commercial use, distribution and reproduction in any medium, provided the original author and source are credited."